Pending Lawsuits Update
As of July 2024, 8,192 hair relaxer lawsuits were still pending in MDL No. 3060, overseen by U.S. District Judge Mary M. Rowland. The ongoing litigation reflects continued concern over the alleged cancer risks associated with hair relaxer products.
FDA Formaldehyde Ban Delayed
Despite previous announcements, the FDA has not yet implemented a ban on formaldehyde in hair relaxer products as planned.
Status Conference Held in Hair Relaxer Class Action Lawsuit
Judge Rowland facilitated a status conference for the hair relaxer class action MDL, focusing on the procedure for addressing evidence on causation. The defense suggested a sequential approach, dealing first with general causation. In contrast, the plaintiffs argued this method would delay the process.
Revlon's Dismissal Request
Amidst bankruptcy proceedings, Revlon has requested the dismissal of 552 hair relaxer lawsuits. The company argues that the claims were not filed in a timely manner according to its bankruptcy agreement.
Motion for Sanctions Against Avlon
Plaintiffs have filed a motion for sanctions against Avlon, accusing the company of inadequate discovery practices. This development highlights ongoing issues with document production in the litigation process.
First Trials Scheduled for Hair Relaxer Lawsuit
The initial bellwether trials for the hair relaxer MDL have been set, with the first trial scheduled for November 3, 2025, and a second trial on February 2, 2026.
FDA Proposes Formaldehyde Ban
Responding to the health risks associated with hair relaxers, the FDA proposed a new rule to ban the use of formaldehyde in all hair relaxer products. This regulatory action is directly related to the chemical's toxicity and its association with various cancers
Hair Relaxer MDL Witness a Surge With Nearly 4,000 New Cases in Just One Month
October 2023 marked a significant escalation in the hair relaxer Multi-District Litigation (MDL), with nearly 4,000 new cases filed, bringing the total to 6,027. Of these, 5,996 cases are still pending, representing a staggering 166% increase since September.
Individuals who are looking to join the hair relaxer Multi-District Litigation must understand both the eligibility criteria and the filing process. Here’s a guide to help you navigate if you qualify and the steps involved.
To be eligible for filing a lawsuit in the hair relaxer MDL, you need to meet the following criteria:
Eligible plaintiffs can initiate a lawsuit directly in the MDL court or transfer an existing suit to the MDL. This consolidation under one judge aims to streamline proceedings for numerous cases with similar allegations.
If you or a loved one has suffered complications due to a hair relaxer product, it’s important to seek legal advice to understand your rights and options.
Get Started
The statute of limitations is a legal principle that defines the timeframe within which you must file a lawsuit after an injury. This timeframe varies by state and is particularly relevant for hair relaxer lawsuits due to the nature of the injuries involved, which may not become apparent immediately.
Each state has its own rules for the statute of limitations on personal injury claims, including those related to product liability. For hair relaxer lawsuits, this period generally ranges from two to six years, starting from when the injury was discovered or should have been reasonably discovered.
This discovery rule is crucial because injuries such as cancers may not be diagnosed until years after exposure to harmful chemicals.
If you file a lawsuit after the statute of limitations has expired, your case will likely be dismissed without being heard, which can prevent you from pursuing compensation. This is why it is essential to be aware of the timelines and act within them to preserve your legal rights.
Because of the complexities of the statute of limitations, it is advisable to seek advice from a lawyer who specializes in personal injury or product liability law. An attorney can provide guidance tailored to your situation, including an accurate timeline for filing a lawsuit based on the specific laws of your state.
To understand the health risks associated with chemical hair treatments, you need to familiarize yourself with both the types of treatments in question and the specific chemicals they contain. These products often include harsh substances that can lead to significant health issues, especially with long-term or frequent use.
Chemical hair treatments designed to alter hair texture come in various forms, each with potential risks. Here’s a brief look at the most common types:
After choosing a treatment type, it's crucial to consider the specific products and their ingredients, as these can vary in terms of strength and potential side effects.
The safety concerns surrounding hair relaxers are largely due to the chemicals they contain, which can be hazardous to both hair and overall health:
Understanding these chemicals and their effects can help you make safer choices in hair care. Choosing products wisely and following application guidelines meticulously reduces the risk of adverse effects, ensuring better hair and scalp health.
Fibroids are benign tumors that grow within the muscle tissue of the uterus. They are among the most common reproductive system tumors in women, often leading to heavy menstrual bleeding, pain during periods, and pelvic discomfort. While they are not cancerous, fibroids can significantly impact a woman's quality of life and fertility.
Research has indicated a potential link between the use of hair relaxers and the increased risk of developing fibroids, particularly among African American women. Studies suggest that the chemicals in hair relaxers, which can penetrate the scalp through lesions or burns, might disrupt hormonal balance and contribute to fibroid development.
For instance, a study noted that women who frequently used hair relaxers over a decade showed a higher occurrence of fibroids. This link appears to be influenced by the chemicals in relaxers, which act as endocrine disruptors, affecting estrogen levels, which play a crucial role in fibroid growth. [1,2]
Uterine cancer involves the development of cancerous cells in the tissues of the uterus, typically presenting as endometrial cancer, which affects the lining of the uterus. It's a significant health concern and is particularly prevalent among postmenopausal women. Symptoms may include abnormal vaginal bleeding, pelvic pain, and weight loss, though early stages may be asymptomatic.
Recent studies have highlighted a concerning link between the frequent use of chemical hair relaxers and an increased risk of uterine cancer. These products, which often contain potent chemicals like formaldehyde and phthalates, are thought to contribute to higher cancer risks due to their endocrine-disrupting properties.
An NIH study reported that women who used hair straighteners more than four times a year had more than twice the risk of developing uterine cancer by age 70 compared to non-users. Moreover, a BWHS has found that women who frequently use hair relaxers are at a higher risk of developing uterine cancer compared to those who do not use these products. [3,4]
Ovarian cancer is a serious disease where malignant cells form in the tissues of the ovaries. It's known for being particularly dangerous because it often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ovarian cancer is more challenging to treat and is frequently fatal.
Recent studies note a potential increase in ovarian cancer risk among women who frequently use hair relaxers along with other hair straightening products. This study suggested that the chemicals in these products, which include known endocrine disruptors, could be contributing to this increased risk.
Additionally, Drugwatch reports that further research has indicated that the frequent use of hair straighteners and relaxers, and possibly permanent hair dyes, might be associated with an increased occurrence of ovarian cancers. [5,6]
Breast cancer arises when cells in the breast begin to grow uncontrollably. This growth can lead to the formation of a tumor that is often detectable by an x-ray or felt as a lump. Symptoms of breast cancer can vary but typically include a new lump in the breast, changes in breast shape or size, and skin changes like dimpling.
Research has shown a potential link between the use of hair relaxers and an increased risk of breast cancer. Chemicals found in hair relaxers, such as formaldehyde, parabens, and phthalates, are known to be endocrine disruptors and carcinogens. These substances can interfere with the hormonal system and potentially lead to breast cancer.
Namely, one study found that regular use of hair straightening chemicals or relaxers increased breast cancer risk by 31%. Additional research noted a higher risk of breast cancer associated with the use of hair straighteners and relaxers. This risk was particularly noted in frequent users of these products. [7,8]
If you or a loved one has suffered a disease due to hair relaxer chemicals, explore your options for securing the compensation needed to support your recovery and future well-being.
Get Started
In the ongoing litigation concerning hair relaxer products linked to various cancers, numerous companies have been named as defendants:
It's important to note that as these legal proceedings evolve, additional companies may be added to the list of defendants based on new evidence or legal arguments presented in court.
Identifying who is at fault for a hair relaxer injury and understanding common defenses are crucial steps in building a strong legal case. If you or a loved one is pursuing a spinal cord injury lawsuit, seeking expert legal advice can help you navigate these complexities and develop a robust strategy to secure the compensation you deserve.
Get Started
Currently, there is no standalone class action lawsuit specifically for uterine cancer claims related to hair relaxer products. Instead, these claims have been incorporated into a larger Multi-District Litigation (MDL No. 3060) in the US District Court for the Northern District of Illinois.
Determining potential settlement amounts for hair relaxer lawsuits involves navigating a complex array of factors. The severity of the medical condition, the strength of the evidence connecting the hair relaxer to the ailment, and unique individual circumstances all play a crucial role in shaping the settlement figures.
Historically, settlements in product liability cases can vary widely. For severe cases, such as those involving cancer, settlement amounts often range from $100,000 to $1,500,000. These higher figures reflect the serious nature of the illness and the substantial impact it has on the individual's life.
The settlement amounts tend to be lower for less severe conditions; however, depending on the specifics of each case, even these lesser conditions can still attract significant settlements.
The timeline for settling hair relaxer lawsuits remains uncertain due to the intricate nature of these cases. They often involve complex legal and medical questions that necessitate extensive evidence gathering and expert testimonies. This meticulous process can significantly prolong the pretrial phase.
If these cases proceed to trial instead of reaching early settlements, the timeline could extend even further. Trials are typically lengthy, involving multiple stages from jury selection to final verdict, all of which contribute to a prolonged process.
Currently, considering the ongoing progression and the scheduling of some trials, a resolution might not be reached until late 2025 or even beyond. This projection takes into account the various stages involved in litigation, from initial filings to potential appeals.
To qualify for a hair relaxer lawsuit, individuals must have used hair relaxer products and subsequently developed health issues potentially linked to these products, such as cancer, hormonal disorders, or scalp injuries.
Settlement amounts in hair relaxer cancer lawsuits can vary widely, but the amounts awarded in similar cases typically range from $100,000 to $1,500,000, depending on the severity of the injury and the strength of the evidence linking the product to the injury.
Yes, scientific studies and ongoing lawsuits suggest that chemicals in hair relaxers, such as phthalates and formaldehyde, may increase the risk of developing cancers, including uterine, ovarian, and breast cancer.
Brands frequently named in hair relaxer lawsuits include L'Oréal USA, Inc., SoftSheen-Carson, Strength of Nature Global, LLC, Namaste Laboratories LLC, and Dabur International.
As of now, there have been no publicized settlements or verdicts awarded in the hair relaxer lawsuits. These cases are still in the stages of pretrial proceedings, with many legal and factual issues yet to be resolved.
Submit your inquiry through our contact form to start your search for legal assistance. Our directory connects you with experienced lawyers in a variety of practice areas, ensuring you have access to advice when you need it most.